Propionic acid and neurofilament light chain in multiple sclerosis
Brain · 07.07.2026 · 149 (7) · 2187-2188
DOI: 10.1093/brain/awag192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 06.07.2026. Verfasst von Sofia Sandgren und 2 weiteren Autor:innen. Beteiligte Einrichtung: Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Department of Neurology, University Hospital and…. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
This scientific commentary refers to ‘Propionic acid in multiple sclerosis: a phase 2b, double blind, randomized placebo-controlled trial’, by Moser et al. (https://doi.org/10.1093/brain/awag099).
Autor:innen und Institutionen
- Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Department of Neurology, University Hospital and University of Basel, Basel 4031, Switzerland.
- Department of Biomedicine, University Hospital and University of Basel, Basel 4031, Switzerland.
- Department of Clinical Research, University Hospital and University of Basel, Basel 4031, Switzerland.
ORCID-Profile: David Leppert, Jens Kuhle
Zitieren
APA
Sandgren, S., Leppert, D., & Kuhle, J. (2026). Propionic acid and neurofilament light chain in multiple sclerosis. Brain, 149(7), 2187-2188. https://doi.org/10.1093/brain/awag192
Vancouver
Sandgren S, Leppert D, Kuhle J. Propionic acid and neurofilament light chain in multiple sclerosis. Brain. 2026;149(7):2187-2188. doi:10.1093/brain/awag192
BibTeX
@article{Sandgren2026,
author = {Sandgren, Sofia and Leppert, David and Kuhle, Jens},
title = {Propionic acid and neurofilament light chain in multiple sclerosis},
journal = {Brain},
year = {2026},
volume = {149},
number = {7},
pages = {2187--2188},
doi = {10.1093/brain/awag192}
}
EUVIMED